Xiamen Amoytop Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	553.16	371.82	412.96	301.24	285.42
Trading Asset Securities	462.48	289.96	257.08	270.78	196.38
Cash & Short-Term Investments	1,016	661.79	670.04	572.02	481.8
Cash Growth	53.47%	-1.23%	17.14%	18.73%	3.53%
Accounts Receivable	1,244	808.52	441.02	223.05	206.28
Other Receivables	22.22	22.34	17.87	20.17	21.67
Receivables	1,266	830.86	458.9	243.22	227.94
Inventory	414.9	263.55	187.02	129.73	116.49
Other Current Assets	33.87	70.9	24.24	10.64	8.19
Total Current Assets	2,730	1,827	1,340	955.61	834.42
Property, Plant & Equipment	966.6	686.76	490.85	389.77	192.92
Goodwill	64.48	-	-	-	-
Other Intangible Assets	359.23	170.85	191.54	121.69	146.91
Long-Term Deferred Tax Assets	97.53	69.09	43.66	47.18	34.96
Long-Term Deferred Charges	63.39	221.2	176.7	229.25	169.14
Other Long-Term Assets	91.91	75.43	112.98	26.05	44.99
Total Assets	4,374	3,050	2,356	1,770	1,424
Accounts Payable	97.38	57.76	39.73	50.91	8.14
Accrued Expenses	288.37	233.75	244.46	159.55	120.4
Short-Term Debt	30.65	-	-	-	10
Current Portion of Long-Term Debt	6.09	-	-	-	-
Current Portion of Leases	10.74	5.67	4.16	4.18	5.79
Current Income Taxes Payable	91.28	50.27	48.95	41.97	24.42
Current Unearned Revenue	55.9	63.13	60.05	7.23	5.18
Other Current Liabilities	126.71	10.06	6.31	4.05	3.3
Total Current Liabilities	707.11	420.63	403.66	267.89	177.23
Long-Term Debt	104	-	-	-	-
Long-Term Leases	24.49	3.27	3.76	5.56	9.37
Long-Term Unearned Revenue	36.51	32.96	40.62	47.68	51.25
Long-Term Deferred Tax Liabilities	7.7	0.93	0.41	15.15	5.54
Other Long-Term Liabilities	44.13	39.31	31.25	25.99	19.53
Total Liabilities	923.94	497.1	479.69	362.27	262.91
Common Stock	408.19	406.8	406.8	406.8	406.8
Additional Paid-In Capital	528.99	413.14	397.04	397.04	397.04
Retained Earnings	2,512	1,733	1,073	603.76	357.42
Shareholders' Equity	3,450	2,553	1,876	1,408	1,161
Total Liabilities & Equity	4,374	3,050	2,356	1,770	1,424
Total Debt	175.97	8.94	7.92	9.74	25.16
Net Cash (Debt)	839.67	652.85	662.11	562.28	456.63
Net Cash Growth	28.62%	-1.40%	17.76%	23.14%	2.28%
Net Cash Per Share	2.05	1.60	1.63	1.39	1.13
Filing Date Shares Outstanding	408.19	406.8	406.8	406.8	406.8
Total Common Shares Outstanding	408.19	406.8	406.8	406.8	406.8
Working Capital	2,023	1,406	936.53	687.72	657.19
Book Value Per Share	8.45	6.28	4.61	3.46	2.85
Tangible Book Value	3,026	2,382	1,685	1,286	1,014
Tangible Book Value Per Share	7.41	5.86	4.14	3.16	2.49
Buildings	491.9	291.61	135.53	118.65	21.31
Machinery	591.85	392.63	319.97	271.83	177.83
Construction In Progress	99.71	181.56	183.72	135.81	118

Source: S&P Global Market Intelligence. Standard template. Financial Sources.